嘉和美康: 嘉和美康简式权益变动报告书

Core Viewpoint - The report outlines a significant reduction in shareholding by Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) in Jiahe Meikang (Beijing) Technology Co., Ltd., decreasing its stake to 10% due to financial needs and dilution from stock incentives [1][5]. Group 1: Shareholding Changes - The information disclosure obligor reduced its shareholding from 19,569,619 shares (14.19%) to 13,758,560 shares (10.00%) following a series of transactions [7][8]. - The reduction in shareholding was influenced by the company's issuance of restricted stock and stock options, leading to a dilution of the obligor's stake [5][9]. - The total share capital of Jiahe Meikang was adjusted from 137,877,502 shares to 137,585,598 shares as a result of these changes [8][10]. Group 2: Future Plans - The information disclosure obligor plans to reduce its holdings by up to 4,127,566 shares (3.00% of total shares) within the next 12 months through centralized bidding and block trading [5][6]. - As of the report date, the obligor's reduction plan remains incomplete, and future changes in shareholding are uncertain [5][11]. Group 3: Legal Compliance - The report confirms that the information disclosure obligor has complied with relevant laws and regulations, ensuring the accuracy and completeness of the disclosed information [2][12]. - The obligor has not engaged in any other transactions involving the company's shares in the six months prior to the report [10][13].